25 results
424B5
TRML
Tourmaline Bio Inc
26 Jan 24
Prospectus supplement for primary offering
4:08pm
-party payors will be subject to applicable anti-kickback, fraud and abuse, transparency and other healthcare laws and regulations, which, if violated
424B5
TRML
Tourmaline Bio Inc
24 Jan 24
Prospectus supplement for primary offering
9:20pm
relationships with healthcare providers, customers and third-party payors will be subject to applicable anti-kickback, fraud and abuse, transparency
8-K
EX-99.1
TRML
Tourmaline Bio Inc
24 Jan 24
Results of Operations and Financial Condition
5:10pm
other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing … access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk
424B3
fdxz 8yqyo
15 Sep 23
Prospectus supplement
6:31am
S-4/A
jcctfbt
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
yjaf3cbirx6 npwkvqn
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
10-K
x7vyn6vk w7vpcc
17 Mar 22
Annual report
4:31pm